$OKUR Cashflow Statement | Understand Stock

$OKUR

$2.60 +$0.12 (4.85%) Close

$OKUR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation expense
Depreciation and amortization
Amortization/accretion on short-term investments
Changes in the fair value of performance award
Non-cash lease expense
Right-of-use and leasehold improvement impairment expenses
Amortization of right-of-use asset - operating
Loss on disposal of property and equipment
Amortization of debt issuance costs
Non-cash interest expense
Loss on sales of available-for-sale securities
Change in operating assets and liabilities:
Prepaid and other assets
Deferred rent
Accounts payable, accrued and other liabilities
Lease liabilities
Other current and long-term liabilities
Other long-term liabilities
Net cash used in operating activities

Cash flows from investing activities:
Proceeds from sales of marketable securities
Purchases of property and equipment
Purchase of available-for-sale short-term investments
Proceeds from maturities of available-for-sale short-term investments
Net cash (used in) provided by investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock, net of offering costs
Public Offering
ATM facility
Total proceeds from issuance of common stock, net of offering costs

Proceeds from the issuance of common stock in Concurrent Financing
Private Placement
Total proceeds from the issuance of common stock in Concurrent Financing
Repurchase of common stock in connection with common stock repurchase agreement
Payment of issuance costs associated with the Concurrent Financing
Cash acquired in connection with the reverse recapitalization
Payment of reverse recapitalization transaction costs
Proceeds from the issuance of Convertible Preferred Stock
Series B convertible preferred stock
Total proceeds from the issuance of Convertible Preferred Stock

Proceeds from initial public offering, net of offering costs
Payment of issuance costs associated with the issuance of Convertible Preferred Stock
Proceeds from issuance of convertible notes payable
Payment of issuance costs associated with the issuance of convertible notes payable
Proceeds from sale of stock under the employee stock purchase plan
Proceeds from the issuance of common stock for exercises of stock options
Net cash provided by financing activities

Net decrease in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental disclosure of noncash investing activities:
Right-of-use asset obtained in exchange for new operating lease liability
Vesting of unvested exercised options
Issuance of Series C Preferred Stock conversion
Conversion of Series C Preferred Stock
Conversion of convertible note payable
Assets acquired in connection with the reverse recapitalization
Other liabilities assumed in connection with the reverse recapitalization
Reverse recapitalization transaction costs included in accounts payable
Concurrent Financing issuance costs included in accounts payable
Concurrent Financing issuance costs paid by Reneo prior to Merger

Comments